Integer Holdings Corp., Texas, has announced the close of its acquisition of Oscor Inc., a privately held company that designs, develops, manufactures, and markets a comprehensive portfolio of highly specialized medical devices, venous access systems, and diagnostic catheters and implantable devices.
The acquisition expands Integer’s cardiovascular and neurostimulation product portfolio through broadened product offering and addition of low-cost manufacturing capacity. In addition, the acquisition further broadens Integer’s research and development capabilities and expands its manufacturing presence to the Dominican Republic, augmenting Integer’s already extensive global footprint and manufacturing capabilities.
“Since launched by my father, Dr. Peter Osypka, nearly 40 years ago, Oscor has been a pioneer in the field of implantable medical technology and electrophysiology,” said Thomas Osypka, Oscor’s owner, president, and CEO. “I am proud of Oscor’s strong record of accomplishments, which the team can now accelerate by uniting with Integer.”
For more information
